Phreesia faces securities class action

Faruqi & Faruqi, LLP has filed a federal securities class action lawsuit against Phreesia, Inc., alleging that the company and its executives violated federal securities laws. The complaint states that Phreesia made false and misleading statements and failed to disclose the true state of its slowing demand and reduced visibility in key revenue streams, particularly weakened pharmaceutical marketing commitments in its Network Solutions segment. On March 30, 2026, Phreesia announced its financial results and significantly reduced its revenue guidance for fiscal year 2027, attributing the reduction to macroeconomic factors and weaker pharmaceutical marketing. Following this announcement, Phreesia's stock price dropped by $3.03 per share, or 26.56%, to close at $8.38 per share on March 31, 2026. Investors who purchased Phreesia securities between May 8, 2025, and March 30, 2026, are encouraged to seek the role of lead plaintiff by the July 13, 2026 deadline.